drugset / Trial / NCT07678463

A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants

NCT07678463 ↗

Phase 1 Recruiting 90 enrolled QuantX Biosciences, Inc.
RandomizedSequentialDouble-blindBasic science

Summary

The primary purpose of this study is to evaluate the safety and tolerability of QX-4533 following oral administration of single and multiple ascending doses in healthy participants.

Timeline

Start
2026-07-10
Primary completion
2026-12-25
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject QX-4533 Unknown — Oral

Indications

No indication recorded.